Lung Cancer,Other Cancers Osimertinib Combo in Untreated EGFR-Mutated Non-squamous NSCLC: OPAL Study May 15, 2023
Lung Cancer,Other Cancers Toripalimab Plus Chemotherapy in Advanced Lung Cancer: CHOICE-01 Trial May 15, 2023
Lung Cancer,Other Cancers Blood TMB Predicts Response to Camrelizumab Combo in Advanced Lung Cancer: Biomarker Analyses May 15, 2023
Breast Cancer,Other Cancers Tucatinib and Trastuzumab Combo as Maintenance Therapy for HER2+ Breast Cancer May 15, 2023
Breast Cancer,Other Cancers PIK3CA and ESR1 Mutations in Circulating Tumor DNA: MONARCH-2 Study Analysis May 15, 2023
Breast Cancer,Other Cancers MAINTAIN Trial: Fulvestrant or Exemestane +/- Ribociclib After Progression on CDK 4/6I for HR+, HER2- MBC May 10, 2023
Breast Cancer,Other Cancers MINDACT Trial: Patients with Ultralow-Risk 70-Gene Signature Show Positive Outcome May 10, 2023
